These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10520225)

  • 1. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat.
    Yamada M; Kawai M; Kawai Y; Mashima Y
    Curr Eye Res; 1999 Oct; 19(4):300-4. PubMed ID: 10520225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
    Ghosh AK; Hirasawa N; Niki H; Ohuchi K
    J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.
    Boyan BD; Lohmann CH; Sisk M; Liu Y; Sylvia VL; Cochran DL; Dean DD; Schwartz Z
    J Biomed Mater Res; 2001 Jun; 55(3):350-9. PubMed ID: 11255188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
    Castro MR; Lutz D; Edelman JL
    Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites.
    Ottino P; Bazan HE
    Curr Eye Res; 2001 Aug; 23(2):77-85. PubMed ID: 11840344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor.
    Yamamoto T; Nozaki-Taguchi N
    Brain Res; 1996 Nov; 739(1-2):104-10. PubMed ID: 8955930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COX-1 and COX-2.
    Blikslager AT; Zimmel DN; Young KM; Campbell NB; Little D; Argenzio RA
    Gut; 2002 May; 50(5):615-23. PubMed ID: 11950805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and vascular effects of cyclooxygenase-2 in brain.
    Brian JE; Moore SA; Faraci FM
    Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ethanol on the expression of cyclo-oxygenase in cultured cortical astrocytes and neurons.
    Luo J; Lindström CL; Donahue A; Miller MW
    J Neurochem; 2001 Mar; 76(5):1354-63. PubMed ID: 11238720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism.
    Nédélec E; Abid A; Cipolletta C; Presle N; Terlain B; Netter P; Jouzeau J
    Biochem Pharmacol; 2001 Apr; 61(8):965-78. PubMed ID: 11286988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis.
    Foitzik T; Hotz HG; Hotz B; Wittig F; Buhr HJ
    Hepatogastroenterology; 2003; 50(52):1159-62. PubMed ID: 12846004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
    Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
    Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
    J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.